Altered kinetics of CD4(+) T cell proliferation and interferon-gamma production in the absence of CD8(+) T lymphocytes in virus-infected beta 2-microglobulin-deficient mice

被引:10
作者
Vikingsson, A [1 ]
Pederson, K [1 ]
Muller, D [1 ]
机构
[1] UNIV WISCONSIN,DEPT MED MICROBIOL & IMMUNOL,MADISON,WI 53706
关键词
D O I
10.1006/cimm.1996.0276
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD8(+) T cells are the major mediators of cytotoxic T cell activity controlling viral infections in normal mice. CD8(+) T cells have also been implicated in regulating the activity of other immune cells. We have examined the possible regulatory role of CD8(+) T cells on CD4(+) T cells by comparing immune responses in mice expressing normal CD8(+) T cell responses and in CD8(+) T cell-deficient beta 2-microglobulin ''knockout'' mice. In normal mice, infection with lymphocytic choriomeningitis virus (LCMV) results in a biphasic T cell immune response. First, CD8(+) T cells proliferate and produce interferon-gamma (IFN-gamma), and then 2 to 4 days later CD4(+) T cells proliferate and produce IFN-gamma. CD8(+) T cell activity is not detected during LCMV infection in beta 2-microglobulin-deficient mice. However, in beta 2-microglobulin-deficient mice the CD4(+) T cell expansion is exaggerated and occurs 2 days earlier than observed in normal mice. Furthermore, the CD4(+) T cells have substantial cytotoxic activity, which is not observed in the CD4(+) T cell population in normal mice. However, CD4(+) T cell IFN-gamma production in beta 2-microglobulin-deficient mice lags behind the proliferative response, resulting in a relative delay in overall T cell IFN-gamma production compared to normal mice. Taken together, these data suggest that CD8(+) T cell activation peaks at an earlier time point than CD4(+) T cell activation during the primary immune response to LCMV and that CD8(+) T cells may inhibit CD4(+) T cell proliferation and the development of CD4(+) T cell cytotoxic activity. (C) 1996 Academic Press, Inc
引用
收藏
页码:261 / 268
页数:8
相关论文
共 53 条
[1]   INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF EXPERIMENTAL T-CELL-MEDIATED AUTOIMMUNE-DISEASE - UP-REGULATION OF T-CELL PROLIFERATION AND DOWN-REGULATION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION [J].
ACHIRON, A ;
MARGALIT, R ;
HERSHKOVIZ, R ;
MARKOVITS, D ;
RESHEF, T ;
MELAMED, E ;
COHEN, IR ;
LIDER, O .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :600-605
[2]   VIRUS-LYMPHOCYTE INTERACTION - T-CELLS OF THE HELPER SUBSET ARE INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS DURING PERSISTENT INFECTION INVIVO [J].
AHMED, R ;
KING, CC ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1571-1576
[3]   NATURAL-KILLER-CELLS CONTRIBUTE TO INFLAMMATION BUT DO NOT APPEAR TO BE ESSENTIAL FOR THE INDUCTION OF CLINICAL LYMPHOCYTIC CHORIOMENINGITIS [J].
ALLAN, JE ;
DOHERTY, PC .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1986, 24 (02) :153-162
[4]  
AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
[5]   ENUMERATION OF IFN-GAMMA-PRODUCING CELLS BY FLOW-CYTOMETRY - COMPARISON WITH FLUORESCENCE MICROSCOPY [J].
ANDERSSON, U ;
HALLDEN, G ;
PERSSON, U ;
HED, J ;
MOLLER, G ;
DELEY, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 112 (01) :139-142
[6]  
BOURGAULT I, 1989, J IMMUNOL, V142, P252
[7]  
CAMPBELL IL, 1994, J IMMUNOL, V152, P716
[8]   PHENOTYPIC ANALYSIS OF THE INFLAMMATORY EXUDATE IN MURINE LYMPHOCYTIC CHORIOMENINGITIS [J].
CEREDIG, R ;
ALLAN, JE ;
TABI, Z ;
LYNCH, F ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1539-1551
[9]   REACTIVATION OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE IN MOUSE PLASMACYTOMA CELLS AND MOUSE T-CELLS [J].
CHANG, CH ;
FODOR, WL ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1465-1469
[10]  
COOPER DA, 1985, LANCET, V1, P537